MUC16 and rheumatoid arthritis: Compared to RA patients, there was no significant difference in CA-125 levels among RA-ILD patients (MD = 15.83; 95% CI: -7.60-39.26; P = 0.19), with high heterogeneity observed (I2 = 97.21%).